Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02651662
Title Study of REGN2810 and REGN1979 in Patients With Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

Cemiplimab

Cemiplimab + Odronextamab

Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
Regeneron Research Facility Baltimore Maryland 21287 United States Details
Regeneron Research Facility Boston Massachusetts 02215 United States Details
Regeneron Research Facility Heidelberg Baden-Wurttemberg 69120 Germany Details
Regeneron Research Facility Barcelona 08035 Spain Details
Regeneron Research Facility Madrid 28033 Spain Details
Regeneron Research Facility Madrid 28040 Spain Details
Regeneron Research Facility Madrid 28041 Spain Details
Regeneron Research Facility Majadahonda 28222 Spain Details
Regeneron Research Facility Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field